PETRAGEN

Petragen is a biotechnology company located in Davie, Florida.

#SimilarOrganizations #More

PETRAGEN

Industry:
Biotechnology Life Science

Founded:
2020-01-01

Address:
Davie, Florida, United States

Country:
United States

Status:
Active

Contact:
646-504-6560


Similar Organizations

agmedica-bioscience-logo

Agmedica Bioscience

Agmedica Bioscience is a life science biotechnology company located in Chatham.

not_available_image

Mrm Proteomics

Mrm Proteomics is a biotechnology company located in Victoria.

More informations about "Petragen"

Petragen

Contact Information. 245 First Street Cambridge, MA 02142 (617) 302-6670See details»

Petragen - Crunchbase Company Profile & Funding

Organization. Petragen . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Petragen is a biotechnology company spun out of …See details»

Team — Petragen

Demetrios Braddock, MD, PhD CSO, Scientific Founder. Dr. Braddock is an Associate Professor of Pathology at Yale University where he has spent the past 20 years building his lab as an engine of biologic therapeutics; One of the …See details»

Petragen Company Profile 2024: Valuation, Funding & Investors

Petragen General Information Description. Developer of novel therapeutics intended to treat adults having periodontal disease. The company develops medicines for diseases, enabling …See details»

Petragen - Funding, Financials, Valuation & Investors - Crunchbase

Petragen is a biotechnology company spun out of Yale University and the NIH focused on novel therapies for periodontal disease ... Products. Resources. Pricing. Resources. Log In. …See details»

Investor Relations — Petragen

Apr 15, 2021 Contact Information. 245 First Street Cambridge, MA 02142 (617) 302-6670See details»

Petragen - Crunchbase

Petragen is a biotechnology company spun out of Yale University and the NIH focused on novel therapies for periodontal disease. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. …See details»

Petragen - Company Profile - Tracxn

Oct 20, 2024 Petragen - R&D company focused on manufacturing of periodontal drugs for multiple therapeutic areas. Raised funding from 1 investor.See details»

Petragen - Raised Funding from 1 investor - Tracxn

Nov 27, 2024 Petragen funding & investors. R&D company focused on manufacturing of periodontal drugs for multiple therapeutic areas. 2020 • Davie (United States) • Funding RaisedSee details»

Petragen, Inc. - Who is raising money? | SEC filings of fundraisings ...

Feb 4, 2021 Petragen, Inc. raised $650,726 from 16 investors on 2021-02-04. Who is raising money? Petragen, Inc. Funding details Petragen, Inc. Industry: Biotechnology CIK Number: …See details»

Petragen - Products, Competitors, Financials, Employees, …

Petragen is a company focused on the healthcare sector, specifically in the domain of periodontal disease therapeutics. The company's main offering is the development of novel treatments for …See details»

Petragen, Inc. - fund raising filing - Form Ds

Feb 4, 2021 Petragen, Inc. - Most recent fund raising on February 16, 2022 raised $1,231,581 in Equity. FormDs.com . Newest; Filter; Local; Petragen, Inc. Industry: Biotechnology (See others …See details»

Petragen Inc. Company Profile | Davie, FL - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Petragen Inc. of Davie, FL. Get the latest business insights from Dun & Bradstreet.See details»

Petragen - Updates, News, Events, Signals & Triggers - Crunchbase

Organization. Petragen . Connect to CRM . Save . Summary Financials People Signals & News Similar Companies. Recent News & Activity. Edit Recent News & Activity Section. Funding …See details»

Petragen Stock Price, Funding, Valuation, Revenue ... - CB Insights

See Petragen funding rounds, investors, investments, exits and more. Evaluate their financials based on Petragen's post-money valuation and revenue. Petragen Stock Price, Funding, …See details»

Petragen discovers new ENPP1 inhibitors | BioWorld

Oct 1, 2024 Gilead Sciences Inc. terminated a potential $785 million licensing deal with Yuhan Corp. inked in 2019 to develop metabolic dysfunction-associated steatohepatitis...See details»

Corporate Update — Petragen

Skip to Content Home TeamSee details»

PETRAGEN - K2014283057 - South Africa - B2BHint

Name PETRAGEN. Status. Deregistration due to annual return non compliance; Jurisdiction South Africa. Enterprise number K2014283057. Incorporation Date 02 Feb 2015 (9 years ago) …See details»

Series A - Petragen - 2022-11-01 - Crunchbase

Organization Name . Petragen . Announced Date Nov 1, 2022; Funding Type ...See details»

linkstock.net © 2022. All rights reserved